Managing hypoglycaemia

Minimising hypos

Page Highlights

  • The challenge of keeping HbA1c low without increasing the risk of hypos

HbA1c: an important measure of how effectively diabetes can be managed using a measure of the amount of glucose that has attached itself to each red blood cell over the preceding 2-3 months to assess the level of diabetes control.

The DCCT (Diabetes Control and Complications Trial) study confirmed that lowering HbA1c by just 1% can decrease the risk of developing microvascular complications by up to 40%.* HbA1c should be monitored every 3 months with the goal of keeping it below 7% (53 mmol/L) or at the target set by your physician.

Normal glucose values vary between 4.0 and 7.8 mmol/L, and you may want to consider trying to achieve these targets in daily life with self-monitoring of blood glucose (SMBG) levels using a personal glucose meter.*

What can I say? Now with the pump it's no longer diabetes controlling me, but it's me having control over diabetes.

- TERESA

Many people find it a challenge to keep HbA1c low in target range without increasing the risk of hypoglycaemia. Insulin pump therapy enables instant adjustments in insulin requirements.

Achieving blood glucose control is therefore important. Some of the best ways to do this while reducing the occurance of hypoglycaemia are:

  • Dosing insulin more regularly in smaller amounts*
  • Balancing glucose levels before and after exercise
  • Adjusting insulin dose to match the carbohydrates in meals
  • Adjusting insulin dosing according to daily activities
  • Knowing when and how to adjust therapy by monitoring glucose levels throughout the day

It can be a challenge to reach and maintain the HbA1C goal whilst minimising the risk of hypoglycaemia. Insulin pump therapy enables adjustments in insulin requirements to meet the body`s needs.

So, what else can someone living with Type 1 diabetes do to reduce hypoglycaemia?

REFERENCES

  • * References are kept on file and are available on request; please contact your local Medtronic representative for copies.

 

The content and all information provided on this website is for your informational use only and is not intended to be a substitute for professional medical advice, diagnosis or treatment in any manner. The patient stories provided are experiences specific to a particular patient. Responses to a treatment may vary from patient to patient. Always talk with your physician about diagnosis and treatment information and ensure that you understand and carefully follow that information.

© 2016 Medtronic International Trading Sarl™. All Rights Reserved. No part of this website may be reproduced or utilized in any form or by any means without permission from Medtronic International Trading Sarl. MiniMed, Bolus Wizard, SMARTGUARD, Guardian, Enlite and CareLink are trademarks of Medtronic, Inc. and its subsidiaries. CONTOUR is a trademark of Bayer Healthcare LLC.